Mustang Bio (MBIO) Operating Leases (2019 - 2024)
Mustang Bio (MBIO) posted quarterly Operating Leases of $422000.0 for Q4 2024, down 78.67% year-over-year from $2.0 million in Q1 2024, and down 57.8% quarter-over-quarter from $1.0 million in Q3 2024.
Mustang Bio (MBIO) Operating Leases (2019 - 2024) Analysis & Trends
Mustang Bio (MBIO) has reported Operating Leases for 6 consecutive years, with $422000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Operating Leases fell 78.67% year-over-year to $422000.0; the TTM figure through Dec 2024 stood at $422000.0 (down 78.67% YoY), while the FY2024 annual figure was $422000.0, down 78.67% from the prior year.
- Operating Leases eased to $422000.0 in Q4 2024 per MBIO's latest filing, from $1.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $3.9 million in Q4 2022 and bottomed at $422000.0 in Q4 2024.
- Historically, Operating Leases has averaged $2.1 million across 5 years, with a median of $2.1 million in 2020.
- Annual changes were most pronounced in 2023 — Operating Leases soared 145.28% — and 2024, when it slumped 78.67%.
- Mustang Bio's Operating Leases stood at $2.2 million in 2020, then dropped by 9.09% to $2.0 million in 2021, then jumped by 95.0% to $3.9 million in 2022, then slumped by 49.28% to $2.0 million in 2023, then plunged by 78.67% to $422000.0 in 2024.
- Business Quant data shows MBIO's Operating Leases at $422000.0 in Q4 2024, $1.0 million in Q3 2024, and $1.1 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Mustang Bio | 3.82 Mn | 3.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 422,000.00 |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 2.40 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 2.65 Mn |
| Mar 31, 2023 | 3.90 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 1.82 Mn |
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 2.20 Mn |
| Sep 30, 2020 | 2.02 Mn |
| Jun 30, 2020 | 2.40 Mn |
| Mar 31, 2020 | 2.16 Mn |